US Consumer Health Industry In 2023: Mandatory Listing Has Supplement Sector’s Attention

Chief executives of OTC drug and supplement industry trade groups discussed potential market and regulatory developments affecting their members’ businesses. HBW Insight reports here on whether support will emerge in Congress for FDA to gain MPL authority for all supplements sold in US.

• Source: Shutterstock

The US dietary supplement industry begins 2023 watching Congress for signs of support among lawmakers for granting the Food and Drug Administration an authority which has generated disagreement in the industry.

Chief executives of OTC drug and supplement industry trade groups recently discussed questions about potential market and regulatory developments affecting...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation